12 Health Care Stocks Moving In Monday's After-Market Session
Portfolio Pulse from Benzinga Insights
In Monday's after-market session, several health care stocks experienced significant price movements. Gainers included Biofrontera, Tivic Health Systems, Cano Health, icad, Evelo Biosciences, and CalciMedica, while losers were SCWorx, Know Labs, Oncorus, Humanigen, Infinity Pharmaceuticals, and Perspective Therapeutics.
June 19, 2023 | 9:38 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Biofrontera shares rose 52.2% to $0.67 during Monday's after-market session, with trading volume reaching 2.3 million shares.
Biofrontera's significant price increase of 52.2% and high trading volume of 2.3 million shares indicate strong investor interest, which could lead to further short-term gains.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
CalciMedica stock moved upwards by 12.32% to $5.65, with a market value of their outstanding shares at $31.9 million.
CalciMedica's 12.32% price increase indicates investor interest, which could lead to further short-term gains.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
Cano Health stock increased by 25.6% to $1.57, with trading volume closing at 2.1 million, 46.6% of its average full-day volume over the last 100 days.
Cano Health's 25.6% price increase and trading volume of 2.1 million shares indicate investor interest, which could result in further short-term gains.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
Evelo Biosciences stock moved upwards by 16.71% to $0.15, with trading volume hitting 60.4 million shares, 1358.3% of its average volume over the last 100 days.
Evelo Biosciences' 16.71% price increase and extremely high trading volume of 60.4 million shares indicate strong investor interest, potentially leading to further short-term gains.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
icad stock moved upwards by 17.94% to $1.38, with trading volume closing at 115.0K, 66.3% of its average full-day volume over the last 100 days.
icad's 17.94% price increase and trading volume of 115.0K shares suggest investor interest, which could lead to further short-term gains.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
Tivic Health Systems stock rose 31.87% to $0.13, with trading volume closing at 5.9 million shares, 210.9% of its average volume over the last 100 days.
Tivic Health Systems' 31.87% price increase and above-average trading volume of 5.9 million shares suggest strong investor interest, potentially leading to further short-term gains.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
Perspective Therapeutics shares declined by 8.23% to $0.65, with a market cap of $182.1 million.
Perspective Therapeutics' 8.23% price decrease indicates negative investor sentiment, which could lead to further short-term losses.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
Humanigen shares fell 9.32% to $0.17, with trading volume closing at 19.9 million, 1767.3% of its average full-day volume over the last 100 days.
Humanigen's 9.32% price decline and extremely high trading volume of 19.9 million shares indicate negative investor sentiment, which could lead to further short-term losses.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
Infinity Pharmaceuticals stock fell 8.32% to $0.22, with trading volume closing at 808.7K shares, 109.6% of its average volume over the last 100 days.
Infinity Pharmaceuticals' 8.32% price decline and above-average trading volume of 808.7K shares indicate negative investor sentiment, which could lead to further short-term losses.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
Know Labs shares decreased by 9.78% to $1.2, with a market cap of $58.1 million.
Know Labs' 9.78% price decrease indicates negative investor sentiment, which could lead to further short-term losses.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
Oncorus shares fell 9.64% to $0.12, with trading volume hitting 40.5 million shares, 3079.0% of its average volume over the last 100 days.
Oncorus' 9.64% price decline and extremely high trading volume of 40.5 million shares indicate negative investor sentiment, which could lead to further short-term losses.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
SCWorx stock declined by 20.7% to $0.5 during Monday's after-market session, with trading volume reaching 2.3 million shares, 157.6% of its average volume over the last 100 days.
SCWorx's 20.7% price decline and above-average trading volume of 2.3 million shares indicate negative investor sentiment, which could lead to further short-term losses.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100